FLX Reduced the Levels of Soluble Aβ40 and Aβ42, the Number of β-Amyloid Plaques and the Percentage of Oligodendrocytes Expressing p16 in the Hippocampi of AD Mice. The gene discussed is CDKN2A; the disease is Alzheimer disease.